+1 888-880-9539Email Us Here
MED-C Secures Cornerstone Funding
MED-C has acquired the majority of operating funds needed to launch its first project, a registry based on next generation sequencing (NGS) in lung cancer.
MED-C Secures Cornerstone Funding
MED-C has acquired the majority of operating funds needed to launch its first project, a registry based on next generation sequencing (NGS) in lung cancer.